An Open-Label Phase 1 Study to evaluate the safety and Efficacy of AB-1015 in Patients with Platinum-Resistant Epithelial Ovarian Cancer

Is This Study For You?

Let's Get Started!




CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Bradley Corr

Bradley Corr

Study ID

Protocol Number: 23-0956

More information available at NCT05617755

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers